Related references
Note: Only part of the references are listed.Neutrophil‑to‑lymphocyte ratio is associated with sensitivity to platinum‑based chemotherapy and prognosis in patients with advanced serous ovarian carcinoma
Takeshi Fukuda et al.
Molecular and Clinical Oncology (2021)
Early clearance of serum HE4 and CA125 in predicting platinum sensitivity and prognosis in epithelial ovarian cancer
Yan Rong et al.
JOURNAL OF OVARIAN RESEARCH (2021)
Neoadjuvant immunotherapy for non-small cell lung cancer: State of the art
Jin Kang et al.
CANCER COMMUNICATIONS (2021)
The great escape: tumour cell plasticity in resistance to targeted therapy
Soufiane Boumahdi et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Chemotherapy remains a cornerstone in the treatment of nonsmall cell lung cancer
Robert Pirker
CURRENT OPINION IN ONCOLOGY (2020)
FANCD2-FANCI is a clamp stabilized on DNA by monoubiquitination of FANCD2 during DNA repair
Pablo Alcon et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)
Electrochemical biosensors for the detection of lung cancer biomarkers: A review
Akbar Khanmohammadi et al.
TALANTA (2020)
Targeted therapy and drug resistance in triple-negative breast cancer: the EGFR axis
Sima Lev
BIOCHEMICAL SOCIETY TRANSACTIONS (2020)
Clinical and Molecular Correlates of Tumor Mutation Burden in Non-Small Cell Lung Cancer
Michael F. Sharpnack et al.
LUNG CANCER (2020)
The FANC/BRCA Pathway Releases Replication Blockades by Eliminating DNA Interstrand Cross-Links
Xavier Renaudin et al.
GENES (2020)
The Association Between Heat-Shock Protein Polymorphisms and Prognosis in Lung Cancer Patients Treated With Platinum-Based Chemotherapy
Ting Zou et al.
FRONTIERS IN PHARMACOLOGY (2020)
Chromosome Instability in Fanconi Anemia: From Breaks to Phenotypic Consequences
Benilde Garcia-de-Teresa et al.
GENES (2020)
Photoactivatable Platinum-Based Anticancer Drugs: Mode of Photoactivation and Mechanism of Action
Ziwen Dai et al.
MOLECULES (2020)
Association of variations in platinum resistance-related genes and prognosis in lung cancer patients
Yuan-Kang Zhou et al.
JOURNAL OF CANCER (2020)
CACNA2D3 Enhances the Chemosensitivity of Esophageal Squamous Cell Carcinoma to Cisplatin via Inducing Ca2+-Mediated Apoptosis and Suppressing PI3K/Akt Pathways
Changjun Nie et al.
FRONTIERS IN ONCOLOGY (2019)
MTDH/AEG-1 downregulation using pristimerin-loaded nanoparticles inhibits Fanconi anemia proteins and increases sensitivity to platinum-based chemotherapy
Jianling Bi et al.
GYNECOLOGIC ONCOLOGY (2019)
Multifaceted Fanconi Anemia Signaling
Raymond Che et al.
TRENDS IN GENETICS (2018)
Fanconi anaemia and cancer: an intricate relationship
Grzegorz Nalepa et al.
NATURE REVIEWS CANCER (2018)
P1.15-006 Enriched Environment and Anti-Depressants Enhance Platinum Chemosensitivity of Small Cell Lung Cancer
Y. Wu et al.
Journal of Thoracic Oncology (2017)
Using genetics to predict patient response to platinum-based chemotherapy
Niki Karachaliou et al.
EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT (2017)
Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunities
Sharad Mangal et al.
ACTA PHARMACOLOGICA SINICA (2017)
At the crossroads of cancer stem cells and targeted therapy resistance
Anbang Wang et al.
CANCER LETTERS (2017)
Genetic Variants in Fanconi Anemia Pathway Genes BRCA2 and FANCA Predict Melanoma Survival
Jieyun Yin et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
Analysis of a FANCE Splice Isoform in Regard to DNA Repair
Frederick Bouffard et al.
JOURNAL OF MOLECULAR BIOLOGY (2015)
Epigenetic silencing of MicroRNA-503 regulates FANCA expression in non-small cell lung cancer cell
Ning Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Genetic variants in DNA repair pathway genes and risk of esophageal squamous cell carcinoma and gastric adenocarcinoma in a Chinese population
Wen-Qing Li et al.
CARCINOGENESIS (2013)
Silencing of Fanconi Anemia Complementation Group F Exhibits Potent Chennosensitization of Mitomycin C Activity in Breast Cancer Cells
Jiankun Yu et al.
JOURNAL OF BREAST CANCER (2013)
Fanconi anaemia and the repair of Watson and Crick DNA crosslinks
Molly C. Kottemann et al.
NATURE (2013)
FANCJ Expression Predicts the Response to 5-Fluorouracil-Based Chemotherapy in MLH1-Proficient Colorectal Cancer
Ryota Nakanishi et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
The antitumor agent doxorubicin binds to Fanconi anemia group F protein
Tomoe Kusayanagi et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
Toxicities of Targeted Therapy and Their Management in Kidney Cancer
Giuseppe Di Lorenzo et al.
EUROPEAN UROLOGY (2011)
Downregulation of Fanconi anemia genes in sporadic head and neck squamous cell carcinoma
Volkert B. Wreesmann et al.
ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY AND ITS RELATED SPECIALTIES (2007)
Disruption of the FA/BRCA pathway in bladder cancer
K. Neveling et al.
CYTOGENETIC AND GENOME RESEARCH (2007)
Chemosensitization to cisplatin by inhibitors of the Fanconi anemia/BRCA pathway
D Chirnomas et al.
MOLECULAR CANCER THERAPEUTICS (2006)
The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia
O Levran et al.
NATURE GENETICS (2005)
The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J
M Levitus et al.
NATURE GENETICS (2005)
Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survival
CJ Marsit et al.
ONCOGENE (2004)
Chemosensitizing tumor cells by targeting the Fanconi anemia pathway with an adenovirus overexpressing dominant-negative FANCA
M Ferrer et al.
CANCER GENE THERAPY (2004)
Promoter hypermethylation of FANCF:: Disruption of Fanconi Anemia-BRCA pathway in cervical cancer
G Narayan et al.
CANCER RESEARCH (2004)
Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors
T Taniguchi et al.
NATURE MEDICINE (2003)
A conserved RING finger protein required for histone H2B monoubiquitination and cell size control
WW Hwang et al.
MOLECULAR CELL (2003)
Molecular pathogenesis of Fanconi anemia
T Taniguchi et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2002)
Share Paper
